Rise of Neisseria gonorrhoeae with mosaic penA-34, France, 2018–2023
Antimicrobial Agents and Chemotherapy · 05.08.2026 · 70 (8)
DOI: 10.1128/aac.01919-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.08.2026. Verfasst von François Camelena und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Bacteriology, Hospital Saint-Louis and Lariboisière, Assistance-Publique Hôpitaux de Paris, Paris, France. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Anti-Bacterial Agents, Gonorrhea. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Surveillance of antimicrobial resistance in Neisseria gonorrhoeae was conducted in France from 2018 to 2023. The proportion of isolates with cefixime MIC ≥ 0.032 mg/L increased from 8.1% in 2018–2022 to 23.5% in 2023. This sharp rise was driven by the expansion of two clones, ST1580 and ST16676, carrying the mosaic penA-34.001 and penA-34.007 alleles, respectively. These findings highlight the essential role of genomic surveillance in monitoring the evolution of resistance determinants in N. gonorrhoeae .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Bacteriology, Hospital Saint-Louis and Lariboisière, Assistance-Publique Hôpitaux de Paris, Paris, France.
- Associated Laboratory of the French National Centre for Bacterial Sexually Transmitted Infections, Saint Louis Hospital, Paris, France.
- Paris Cité University, Inserm, IAME, Paris, France.
ORCID-Profile: François Camelena
Zitieren
APA
Camelena, F., Merimèche, M., Mainardis, M., Braille, A., Bercot, B., & ENGON Study Group (2026). Rise of Neisseria gonorrhoeae with mosaic penA-34, France, 2018–2023. Antimicrobial Agents and Chemotherapy, 70(8). https://doi.org/10.1128/aac.01919-25
Vancouver
Camelena F, Merimèche M, Mainardis M, Braille A, Bercot B, ENGON Study Group. Rise of Neisseria gonorrhoeae with mosaic penA-34, France, 2018–2023. Antimicrobial Agents and Chemotherapy. 2026;70(8). doi:10.1128/aac.01919-25
BibTeX
@article{Camelena2026,
author = {Camelena, François and Merimèche, Manel and Mainardis, Mary and Braille, Aymeric and Bercot, Béatrice and ENGON Study Group, ENGON Study Group},
title = {Rise of Neisseria gonorrhoeae with mosaic penA-34, France, 2018–2023},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {8},
doi = {10.1128/aac.01919-25}
}
EUVIMED